Literature DB >> 25963328

Anti-Obesity Pharmacotherapy: The Intercontinental Regulatory Divide.

Andrew J Krentz1, Ken Fujioka, Marcus Hompesch.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25963328     DOI： 10.1007/s40265-015-0404-z

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  9 in total

1.  Food and Drug Administration's Obesity Drug Guidance Document: a short history.

Authors:  Eric Colman
Journal:  Circulation       Date:  2012-05-01       Impact factor: 29.690

2.  Obesity in Europe - does anybody care?

Authors:  Arne Astrup; Stephan Rössner; Nicholas Finer; Luc Van Gaal
Journal:  Expert Opin Pharmacother       Date:  2013-03-22       Impact factor: 3.889

3.  Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

Authors:  W Philip T James; Ian D Caterson; Walmir Coutinho; Nick Finer; Luc F Van Gaal; Aldo P Maggioni; Christian Torp-Pedersen; Arya M Sharma; Gillian M Shepherd; Richard A Rode; Cheryl L Renz
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

4.  Safety of antiobesity drugs.

Authors:  Bernard Man Yung Cheung; Tommy Tsang Cheung; Nithushi Rajitha Samaranayake
Journal:  Ther Adv Drug Saf       Date:  2013-08

Review 5.  Pharmacotherapy for obesity: novel agents and paradigms.

Authors:  Sean Manning; Andrea Pucci; Nicholas Finer
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

Review 6.  Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.

Authors:  A J Krentz; K Fujioka; M Hompesch
Journal:  Diabetes Obes Metab       Date:  2016-06       Impact factor: 6.577

Review 7.  Review paper: Current strategies in the development of anti-obesity drugs and their safety concerns.

Authors:  C S Elangbam
Journal:  Vet Pathol       Date:  2009-01       Impact factor: 2.221

8.  Pharmacotherapies for obesity: past, current, and future therapies.

Authors:  Lisa L Ioannides-Demos; Loretta Piccenna; John J McNeil
Journal:  J Obes       Date:  2010-12-12

Review 9.  Anti-obesity drugs: past, present and future.

Authors:  R John Rodgers; Matthias H Tschöp; John P H Wilding
Journal:  Dis Model Mech       Date:  2012-09       Impact factor: 5.758
  9 in total
  2 in total

1.  Bidens pilosa and its active compound inhibit adipogenesis and lipid accumulation via down-modulation of the C/EBP and PPARγ pathways.

Authors:  Yu-Chuan Liang; Meng-Ting Yang; Chuan-Ju Lin; Cicero Lee-Tian Chang; Wen-Chin Yang
Journal:  Sci Rep       Date:  2016-04-11       Impact factor: 4.379

2.  Effect of orlistat alone or in combination with Garcinia cambogia on visceral adiposity index in obese patients.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb
Journal:  J Intercult Ethnopharmacol       Date:  2016-08-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.